The challenge to further improvements in survival of patients with T-ALL: Current treatments and new insights from disease pathogenesis.
Sign Up to like & getrecommendations! Published in 2020 at "Seminars in hematology"
DOI: 10.1053/j.seminhematol.2020.11.004
Abstract: Survival rates for children and adult patients with T-cell acute lymphoblastic leukemia (T-ALL) have improved during the past decade due to optimization of frontline multiagent chemotherapy regimens. The outcome for relapsed T-ALL after initial intensive… read more here.
Keywords: current treatments; disease; challenge improvements; survival patients ... See more keywords